NEUROP
NeurOp Corporation, a preclinical stage pharmaceutical company, engages in the development of disease activated small molecules for the treatment of central nervous system (CNS) diseases. It offers therapeutics for CNS indications, including ischemia, neuropathic pain, Parkinson's disease, and Alzheimer's disease. The company was incorporated in 2002 and is based in Atlanta, Georgia.
NEUROP
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2002-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.neuropinc.com
Total Employee:
1+
Status:
Active
Contact:
404-941-2350
Email Addresses:
[email protected]
Total Funding:
580 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Google Maps
Similar Organizations
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Current Employees Featured
Founder
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
ATDC
ATDC investment in Seed Round - NeurOp
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
Georgia Research Alliance
Georgia Research Alliance investment in Grant - NeurOp
Official Site Inspections
http://www.neuropinc.com
- Host name: 195.0.153.160.host.secureserver.net
- IP address: 160.153.0.195
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "NeurOp"
About Us - NeurOp Inc.
NeurOp was founded in 2002 by Raymond Dingledine, Ph.D., and Stephen Traynelis, Ph.D., both of the Department of Pharmacology at Emory University School of Medicine, and James McNamara, M.D., chairman of the …See details»
NeurOp, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 www.neuropinc.com. Last update 08 May 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics …See details»
NeurOp, Inc. - LinkedIn
NeurOp, Inc. is a clinical-stage biotechnology company developing new medicines for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage (SAH), …See details»
NeurOp - Overview, News & Similar companies | ZoomInfo.com
Apr 11, 2018 Who is NeurOp. NeurOp, Inc. is a privately held, clinical-stage biopharmaceutical company based in Atlanta, Georgia that is developing small-molecule therapies fo r central …See details»
Product Pipeline NeurOp/BMS - grants.nih.gov
Email: [email protected] . Tel: 404 941 2360. Website: www.neuropinc.com . Company Profile . Industry Sector: Biopharmaceuticals . Company Overview: NeurOp, Inc. is a prec …See details»
NeurOp - Crunchbase Company Profile & Funding
NeurOp is a research company developing different drug compounds. View contacts for NeurOp to access new leads and connect with decision-makers.See details»
NeurOp 2025 Company Profile: Valuation, Funding & Investors
NeurOp General Information Description. Developer of medicines designed to treat central nervous system disorders. The company develops medicines for central nervous system …See details»
NeurOp, Inc. - Home
NeurOp, Inc. is a clinical-stage biotechnology company developing medicines for pain, stroke, subarachnoid hemorrhage and treatment-resistant depression.See details»
NeurOp Company Profile - Office Locations, Competitors, Revenue …
NeurOp has 5 employees at their 1 location. See insights on NeurOp including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Neurop, Inc. | Golden
Neurop, Inc. is an Atlanta-based company founded in 2001.See details»
Management Team - NeurOp Inc.
James O. McNamara, M.D. Executive Chairman Dr. McNamara is a co-founder of NeurOp and has been intimately involved in the operations of the company since its inception. He has been …See details»
NeurOp, Inc - VentureRadar
NeurOp is commercializing research of a critical signaling pathway in the central nervous system into promising drug compound. The company`s... ... Find out more ...See details»
NeurOp – Funding, Valuation, Investors, News
Jan 13, 2016 NeurOp develops medicine to treat central nervous system disorders such as major depression, neuropathic pain, ischemia (stroke) and Alzheimer’s. Based on years of …See details»
NeurOp CEO and Key Executive Team | Craft.co
NeurOp's Executive Chairman is James O. McNamara. Other executives include Robert Zaczek, Chief Scientific Officer; Raymond J. Dingledine, Director and 2 others. See the full leadership …See details»
News & Events - NeurOp Inc.
For more information, please visit www.neuropinc.com or follow us on LinkedIn. NeurOp Announces Positive Topline Data from Phase 1 Studies for Lead Candidate NP10679 for CNS …See details»
Board of Directors - NeurOp Inc.
James O. McNamara, M.D. James O. McNamara, M.D., (Chairman) has been a faculty member for over 30 years in the Duke University School of Medicine where he holds the positions of …See details»
Term title Archives - NeurOp Inc.
Dec 8, 2021 NP10679 is in development to prevent brain ischemia during stroke or subarachnoid hemorrhage. NeurOp, Inc. today announced that it has received a $3.5 million …See details»
neuropinc.co Reviews | check if site is scam or legit| Scamadviser
Check neuropinc.co with our free review tool and find out if neuropinc.co is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API & Data …See details»
NeurOp, Inc | VentureRadar
Website: http://www.neuropinc.com. NeurOp is commercializing research of a critical signaling pathway in the central nervous system into promising drug compound.See details»
Science based on NMDA receptor modulation - NeurOp Inc.
NeurOp is developing a new generation of NMDA receptor modulators to improve treatment of CNS disorders such as severe pain, epilepsy and SAH.See details»